CORC

浏览/检索结果: 共266条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:  Li, Cong;  Lu, Fangxiao;  Lei, Tao;  Yu, Haifeng;  Yang, Haiyan
收藏  |  浏览/下载:22/0  |  提交时间:2020/11/30
Diffuse large B-cell lymphoma with low F-18-fluorodeoxyglucose avidity features silent B-cell receptor signaling 期刊论文
LEUKEMIA & LYMPHOMA, 2020, 页码: 8
作者:  Sheng, Dong;  Li, Ting;  Wang, Wei-Ge;  Li, Meng-Jiao;  Jiang, Kai-Long
收藏  |  浏览/下载:33/0  |  提交时间:2020/07/01
Quantifying The Adhesion Forces of Lymphoma Cells by AFM Single-cell Force Spectroscopy 期刊论文
生物化学与生物物理进展, 2019, 卷号: 46, 期号: 1, 页码: 89-98
作者:  Xiang RW(项荣武);  Liu B(刘斌);  Liu XF (刘小菲);  Li M(李密);  Dang D(党丹)
收藏  |  浏览/下载:54/0  |  提交时间:2019/02/11
Atomic force microscopy in probing tumor physics for nanomedicine 期刊论文
IEEE Transactions on Nanotechnology, 2019, 卷号: 18, 页码: 83-113
作者:  Xi N(席宁);  Wang YC(王越超);  Liu LQ(刘连庆);  Li M(李密)
收藏  |  浏览/下载:33/0  |  提交时间:2018/12/16
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO SEVERE PATIENTS WITH RHEUMATOID ARTHRITIS 期刊论文
ANNALS OF THE RHEUMATIC DISEASES, 2019, 卷号: 78
作者:  Qiu, Wenting;  Chai, Katherine;  Guo, Xinjun;  Zhang, Xin;  Liu, Eugene
收藏  |  浏览/下载:59/0  |  提交时间:2019/12/04
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4
作者:  Xiao, Xiubin;  Bao, Huizheng;  Wang, Ningju;  Ren, Hanyun;  Cen, Xinan
收藏  |  浏览/下载:56/0  |  提交时间:2019/12/05
Improved Outcome of Newly Diagnosed Childhood Mature B-Cell Lymphoma/Leukemia With High Tumor Burden Treated With BFM95-based Protocol Combining Rituximab: A Report From Shanghai, China 期刊论文
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 卷号: 41, 期号: 3
作者:  Lu, Fengjuan;  Fu, Yang;  Wang, Hongsheng;  Zhai, Xiaowen;  Qian, Xiaowen
收藏  |  浏览/下载:20/0  |  提交时间:2019/12/05
Reduced dosage rituximab in the treatment of anti-N-methyl-D-aspartate receptor encephalitis: An observation study in Chinese patients 期刊论文
JOURNAL OF NEUROIMMUNOLOGY, 2019, 卷号: 330
作者:  Deng, Bo;  Yu, Hai;  Liu, Xiaoni;  Yu, Xue;  Zhang, Xiang
收藏  |  浏览/下载:17/0  |  提交时间:2019/12/05
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy 期刊论文
BLOOD, 2019, 卷号: 133, 期号: 2
作者:  Kusumoto, Shigeru;  Arcaini, Luca;  Hong, Xiaonan;  Jin, Jie;  Kim, Won Seog
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/05
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2019, 卷号: 37, 期号: 14
作者:  Leonard, John P.;  Trneny, Marek;  Izutsu, Koji;  Fowler, Nathan H.;  Hong, Xiaonan
收藏  |  浏览/下载:25/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace